STAT5A and neoplasm: As seen in vitro, mice that received Stat5a shRNA-engineered T cells also exhibited significantly faster tumor growth (Supplementary Fig. 8a, b), suggesting that Stat5 indeed also plays an important role in Th9-mediated antitumor activity.